Mechanism of Action : Semaglutide is a GLP-1 receptor agonist
Delayed gastric emptying, gastroparesis-like symptoms, intestinal obstruction, biliary disease, and pancreatic safety concerns were variably reported, with heterogeneous and sometimes conflicting evidence across studies
The researchers saw that, across all therapies, the higher-dose GLP-1 receptor agonists generally demonstrated greater cardiometabolic improvements
Home Pharmaceuticals CYANOCOBALAMIN B12 INJECTION 1,000MCG/ML Cyanocobalamin, USP injection for intramuscular or subcutaneous use
Some common side effects include: Nausea Vomiting Diarrhea Constipation Abdominal pain While less common, some patients using Semaglutide may experience more serious side effects: Hypoglycemia: Combining Semaglutide with insulin or sulfonylureas can increase the risk of low blood sugar
While injectable GLP-1 medications themselves are unlikely to have clinically significant interactions with laxatives, they may delay absorption of other oral medications due to slowed gastric emptying